This inventor holds 2 USPTO granted patents. Top assignee: Hoechst Aktiengesellschaft. Active years: 1985-1993.
Location History:
- Konigstein, DE (1985)
- Konigstein/Taunus, DE (1993)
Company Filing History:
Years Active: 1985-1993
Title: Horst Neubauer: Innovator in Bile Acid Derivatives
Introduction
Horst Neubauer is a notable inventor based in Königstein/Taunus, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of bile acid derivatives. With a total of two patents to his name, Neubauer's work has implications in both medical and pharmaceutical applications.
Latest Patents
Neubauer's latest patents include innovative processes related to bile acid derivatives. The first patent focuses on the preparation and use of these derivatives, which are crucial for various therapeutic applications. The second patent involves a procedure for the immunologic determination of procollagen peptides, specifically type III and type I. This advancement allows for the simultaneous immunological determination of these important antigens.
Career Highlights
Throughout his career, Horst Neubauer has been associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work has contributed to the advancement of biochemistry and has been recognized within the scientific community.
Collaborations
Neubauer has collaborated with esteemed colleagues such as Rupert Timpl and Dietrich Brocks. These collaborations have further enriched his research and have led to significant advancements in their respective fields.
Conclusion
Horst Neubauer's contributions to the field of biochemistry, particularly through his patents on bile acid derivatives and procollagen peptides, highlight his innovative spirit and dedication to scientific advancement. His work continues to influence the pharmaceutical industry and medical research.